-
From Our LabsOpening chemistry education to the world
Novartis taps MOOC technology to share chemistry education with the world
From Our Labs -
From Our LabsHow to address the culture gap between academia and industry in biomedicine
Experts call for significant changes to facilitate the discovery of new treatments.
From Our Labs -
From Our LabsGiraffes have high blood pressure. Why don’t they drop dead?
A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.
From Our Labs -
From Our LabsStopping free radicals at their source
Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.
From Our Labs -
From Our LabsFive things to look for in a scientific mentor
From Our Labs -
From Our LabsHow I built a mini-gut with next to no biology training
From Our Labs -
From Our LabsFixing what’s lost in translation
From Our Labs -
From Our LabsLetters to my younger self: Female scientists share their wisdom
Accomplished female scientists at Novartis share their wisdom born from difficult moments in life.
From Our Labs -
From Our LabsNurturing the life science ecosystem
From Our Labs -
From Our LabsCancer spies find drug-beating covert cells
From Our Labs -
From Our LabsTurning up the heat on tumors
From Our Labs -
From Our LabsVision hacker
Making clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.
From Our Labs